JCM
CELG

JD Capital Management’s Celgene Corp CELG Stock Holding History

JD Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-84,811
Closed -$11M – 27
2017
Q2 		$11M Buy
84,811
+41,172
+94% +$5.04M 2.66% 10
2017
Q1 		$5.43M Buy
+43,639
New +$5.22M 1.76% 14

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JD Capital Management's CELG Position: Q3 2017 in Review

JD Capital Management sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 84,811 shares — an estimated $11M sold.

JD Capital Management first reported a position in CELG in Q1 2017 and held it in 2 quarters. The position peaked at $11M in Q2 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • JD Capital Management reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
  • JD Capital Management sold 84,811 Celgene Corp shares in Q3 2017, an estimated $11M.
  • JD Capital Management first reported a position in Celgene Corp in Q1 2017 and held it in 2 quarters.
  • JD Capital Management's Celgene Corp position peaked at $11M in Q2 2017.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on JD Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.